Company: HRTX
Filing Date: 2025-04-30
Form Type: DEF 14A
Source: 0000950170-25-060882
Chunk: 45

Company: HERON THERAPEUTICS, INC. /DE/
Filing Date: 2025-04-30
Form: DEF 14A
Chunk 45
---
,989 |     |                                                                         |           |     |                                                |      |     | $                                                   |   129,557 |

(1) The amounts reported in the Estimated Future Payouts Under Non-Equity Incentive Plan Awards columns reflect potential

33

payments under the annual cash incentive bonus for Named Executive Officers, if performance for each performance metric had been achieved at the threshold, target or maximum performance levels, and, for purposes of this disclosure, are based on the Named Executive Officers’ base salaries in effect at the end of the fiscal year. Actual payments under the annual cash bonus opportunities earned for fiscal 2024 are reported in the 2024 Summary Compensation Table. See Compensation Discussion and Analysis above for additional details regarding the annual cash bonus opportunities. (2) The amounts reported in this column reflect time-based restricted stock units granted under the 2007 Plan, which vest over four years, with 1/16th of the covered shares vesting on each quarterly anniversary of the grant date, generally subject to the respective grantee’s continued service through the applicable vesting date. (3) The amounts reported in this column reflect the time-based stock options granted under the 2007 Plan, with 1/48th of the covered shares vesting on each monthly anniversary of the grant date, generally subject to the respective grantee’s continued service through the applicable vesting date. (4) The amounts reported in the Grant Date Fair Value of Stock Awards and Option Awards column represent the aggregate grant date fair value of the applicable award, computed in accordance with FASB ASC Topic 718, excluding the effect of estimated forfeitures. The assumptions used in calculating the fair value of the stock awards and options can be found under Note 10 to the Financial Statements in our Annual Report on Form 10-K for the year ended December 31, 2024. 2024 Outstanding Equity Awards at Fiscal Year End The following tables set forth certain information regarding outstanding equity awards granted to our Named Executive Officers that remained outstanding as of December 31, 2024 (all of which were granted under the 2007 Plan or as inducement awards not granted under but subject to the terms and conditions of the 2007 Plan):

| Name           |     | Grant     
 Date      | Option Awards | Number of Securities           
 Underlying Unexercised Options 
 Exercisable                    
 (#)                            |           |     | Unexercisable 
           (#) |         |     |    | Equity Incentive